Neuronetics, which sells a medical system that uses magnetic stimulation to relieve depression, raised $94 million by offering 5.5 million shares at $17, above the range of $14 to $16. Neuronetics plans to list on the Nasdaq under the symbol STIM. Piper Jaffray and William Blair acted as lead managers on the deal.
